Topic 1 - Molecules, Transport and Health

Syllabus
2021
Topic
Level
AS

Learning objectives

1.1Water as a transport solventUnderstand the importance of water as a solvent in transport, including its dipole nature1.2Monosaccharides, disaccharides and polysaccharides(i) know the difference between monosaccharides, disaccharides and polysaccharides, including glycogen and starch (amylose and amylopectin) (ii) be able to relate the structures of monosaccharides, disaccharides and polysaccharides to their roles in providing and storing energy β-glucose and cellulose are not required in this topic.1.3Core Practical 1 - reducing sugars and starchCORE PRACTICAL 1 Use a semi-quantitative method with Benedict’s reagent to estimate the concentrations of reducing sugars and with iodine solution to estimate the concentrations of starch, using colour standards.1.4Glycosidic bonds, condensation and hydrolysisKnow how monosaccharides (glucose, fructose and galactose) join together to form disaccharides (maltose, sucrose and lactose) and polysaccharides (glycogen, amylose and amylopectin) through condensation reactions forming glycosidic bonds, and how these can be split through hydrolysis reactions1.5Triglycerides and saturated or unsaturated lipids(i) know how a triglyceride is synthesised by the formation of ester bonds during condensation reactions between glycerol and three fatty acids (ii) know the differences between saturated and unsaturated lipids1.6Need for hearts and circulationUnderstand why many animals have a heart and circulation (mass transport to overcome the limitations of diffusion in meeting the requirements of organisms)1.7Blood vessel structure and functionUnderstand how the structures of blood vessels (capillaries, arteries and veins) relate to their functions1.8Cardiac cycle and mammalian heart functionKnow the cardiac cycle (atrial systole, ventricular systole and cardiac diastole) and relate the structure and operation of the mammalian heart, including the major blood vessels, to its function Details of myogenic stimulation are not needed at IAS.1.9Haemoglobin, oxygen dissociation and Bohr effect(i) understand the role of haemoglobin in the transport of oxygen and carbon dioxide (ii) understand the oxygen dissociation curve of haemoglobin, the Bohr effect and the significance of the oxygen affinity of fetal haemoglobin compared with adult haemoglobin1.10AtherosclerosisUnderstand the course of events that leads to atherosclerosis (endothelial dysfunction, inflammatory response, plaque formation, raised blood pressure)1.11Blood clotting and cardiovascular diseaseUnderstand the blood clotting process (thromboplastin release, conversion of prothrombin to thrombin and fibrinogen to fibrin) and its role in cardiovascular disease (CVD)1.12Cardiovascular disease risk factorsKnow how factors such as genetics, diet, age, gender, high blood pressure, smoking and inactivity increase the risk of cardiovascular disease (CVD)1.13Antioxidants and cardiovascular disease riskUnderstand the link between dietary antioxidants and the risk of cardiovascular disease (CVD)1.14Core Practical 2 - vitamin C contentCORE PRACTICAL 2 Investigate the vitamin C content of food and drink.1.15Health risk data, correlation and causationBe able to analyse and interpret quantitative data on illness and mortality rates to determine health risks, including distinguishing between correlation and causation and recognising conflicting evidence1.16Study design for health risk factorsBe able to evaluate the design of studies used to determine health risk factors, including sample selection and sample size used to collect data that is both valid and reliable1.17Perceived risk and actual riskUnderstand why people’s perception of risks are often different from the actual risks, including underestimating and overestimating the risks due to diet and other lifestyle factors in the development of heart disease1.18Cholesterol, HDL, LDL and CVD evidence(i) be able to analyse data on the possible significance for health of blood cholesterol levels and levels of high-density lipoproteins (HDLs) and low-density lipoproteins (LDLs) (ii) know the evidence for a causal relationship between blood cholesterol levels (total cholesterol and LDL cholesterol) and cardiovascular disease (CVD)1.19Scientific knowledge and CHD risk reductionUnderstand how people use scientific knowledge about the effect of diet, including obesity indicators, such as body mass index and waist-to-hip ratio, exercise and smoking to reduce their risk of coronary heart disease1.20Treatments for cardiovascular diseaseKnow the benefits and risks of treatments for cardiovascular disease (CVD) (antihypertensives, statins, anticoagulants and platelet inhibitors)

Water's dipole makes it a transport solvent

A water molecule is polar because oxygen attracts the shared electrons more strongly than hydrogen. Oxygen therefore has a partial negative charge (δ\delta-), while each hydrogen has a partial positive charge (δ+\delta+).

Ions and other polar solutes are attracted to these partial charges. Water molecules surround them, separate them and keep them dispersed in solution, so the dissolved particles can move with the water.

Blood plasma transports dissolved glucose, amino acids, mineral ions, urea and carbon dioxide-containing species. Plant transport fluids likewise carry dissolved mineral ions and assimilates between organs.

Water is not a universal solvent: non-polar substances such as lipids dissolve poorly. The key link here is dipole \rightarrow dissolving charged or polar solutes \rightarrow mass transport.

Carbohydrate size and branching match transport and storage roles

A monosaccharide is one sugar unit; glucose, fructose and galactose are examples. A disaccharide contains two monosaccharides joined by a glycosidic bond: maltose is glucose + glucose, sucrose is glucose + fructose, and lactose is glucose + galactose.

A polysaccharide contains many monosaccharide units. Starch is the plant energy store: amylose is an unbranched, coiled chain and amylopectin is branched. Glycogen is the animal energy store and is more highly branched than amylopectin.

Monosaccharides and many disaccharides are small and soluble, making them suitable for transport and immediate respiration. Starch and glycogen are compact and insoluble, so storing many glucose units has little osmotic effect. Branching supplies many ends where enzymes can release glucose.

This Topic requires glycogen, amylose and amylopectin. β\beta-glucose and cellulose are explicitly outside this objective's scope.

Use colour standards to estimate reducing sugar and starch

Benedict's reagent gives a semi-quantitative estimate of reducing sugar after heating: blue changes through green, yellow and orange to brick-red as concentration increases. Iodine changes from orange-brown towards blue-black as starch concentration increases.

  1. Prepare a dilution series of known reducing-sugar or starch concentrations.
  2. Use equal sample and reagent volumes. Heat every Benedict's tube in the same water bath for the same time; do not heat iodine tests.
  3. Test the unknown under identical conditions.
  4. Match its final colour to the closest standard and report the corresponding concentration or range.
  5. Repeat and include a zero-concentration control.

The standards turn a subjective colour observation into an ordered concentration estimate. Keeping volumes, temperature, heating time and viewing conditions constant makes colour the only intended response to concentration.

A colour match is semi-quantitative, not an exact molecular measurement. A negative result means the substance was not detected under the method's conditions.

Condensation builds glycosidic bonds; hydrolysis breaks them

A condensation reaction joins two monosaccharides, forms a glycosidic bond and releases one water molecule. Hydrolysis is the reverse: adding water breaks the glycosidic bond and releases smaller sugars.

Glucose + glucose forms maltose; glucose + fructose forms sucrose; glucose + galactose forms lactose. Repeated condensation of glucose units forms glycogen, amylose or amylopectin.

During digestion, enzyme-catalysed hydrolysis converts disaccharides and polysaccharides into soluble monosaccharides that can be absorbed. In cells, condensation assembles glucose into compact storage polysaccharides.

Condensation forms a bond and releases water; hydrolysis consumes water and breaks the bond. The shared monomer does not make glycogen, amylose and amylopectin structurally identical.

Triglyceride structure explains energy density and saturation

A triglyceride forms when glycerol reacts with three fatty acids in condensation reactions, creating three ester bonds and releasing three water molecules. Its hydrocarbon tails store substantial chemical energy.

A saturated fatty acid has no carbon–carbon double bond; an unsaturated fatty acid has one or more. Double bonds introduce bends, so unsaturated tails usually pack less tightly and have lower melting points.

Long reduced hydrocarbon chains contain many bonds that can be oxidised, giving lipids a high energy value per gram. Their insolubility also makes them compact stores with little osmotic effect.

A fat rich in saturated tails tends to be solid at room temperature, whereas an oil rich in cis-unsaturated tails is more likely to remain liquid. The physical state reflects tail packing, not simply the word ‘lipid’.

One double bond does not make a lipid ‘healthy’ or determine every biological effect. Separate molecular structure, physical state and health evidence.

A circulatory system overcomes diffusion limits in large animals

Diffusion is effective over short distances but becomes too slow when an organism is large or metabolically active. A circulatory system moves substances in bulk between exchange surfaces and tissues.

A pump maintains a pressure gradient and vessels provide a controlled route. The heart sends deoxygenated blood to the lungs and oxygenated blood to body tissues in a double circulation, keeping exchange gradients steep.

An active muscle has a high oxygen demand. Blood flow delivers oxygenated blood close to the cells and removes carbon dioxide, while diffusion completes the final short distance across capillary walls and tissue fluid.

The circulatory system does not replace diffusion: gases and solutes still cross exchange surfaces by diffusion or transport processes. Its role is to shorten effective transport distances and refresh gradients.

Arteries, veins and capillaries are built for different transport jobs

Arteries carry blood away from the heart at high, pulsatile pressure; veins return blood at lower pressure; capillaries form the exchange network between them.

Arteries have thick walls containing elastic tissue, smooth muscle and collagen: elastic recoil maintains pressure, muscle changes lumen diameter, and collagen resists overexpansion. Veins have thinner walls, wide lumens and valves; skeletal-muscle contractions squeeze them and valves prevent backflow. Capillary walls are one endothelial cell thick, giving a short diffusion path.

Many capillaries in parallel provide a very large total cross-sectional area, so blood velocity falls through a capillary bed. Their narrow lumen keeps red blood cells close to the wall, while extensive branching supplies a large exchange area.

Vessels are named by direction relative to the heart, not oxygen content: the pulmonary artery carries deoxygenated blood and the pulmonary vein carries oxygenated blood.

Pressure changes control the cardiac cycle and its valves

One cardiac cycle comprises atrial systole, ventricular systole and cardiac diastole. Contraction raises chamber pressure and relaxation lowers it; valves open only when pressure behind them exceeds pressure ahead.

  1. During atrial systole, the atria contract and complete ventricular filling through open atrioventricular valves.
  2. During ventricular systole, ventricular pressure closes the atrioventricular valves, then opens the semilunar valves so blood enters the pulmonary artery and aorta.
  3. During diastole, the heart relaxes; semilunar valves close and atrioventricular valves reopen as the chambers refill.

The right side pumps through the pulmonary circuit; the thicker left ventricle generates the higher pressure needed for the systemic circuit. The septum prevents mixing, and coronary vessels supply the cardiac muscle.

Valve movement is caused by pressure differences, not by valves actively contracting. Detailed myogenic stimulation is not required at IAS.

Haemoglobin links oxygen loading to carbon dioxide production

Haemoglobin has four haem groups and binds oxygen reversibly. Its oxygen dissociation curve is sigmoid: binding the first oxygen increases affinity for the next, while unloading becomes easier after oxygen begins to dissociate.

At the lungs, high oxygen partial pressure favours oxyhaemoglobin formation. At respiring tissues, lower oxygen partial pressure favours unloading. Most carbon dioxide is carried as hydrogencarbonate ions; some binds to haemoglobin, and haemoglobin also buffers hydrogen ions.

Extra carbon dioxide in active tissue lowers blood pH and reduces haemoglobin's oxygen affinity. This Bohr effect shifts the curve to the right, so more oxygen is released at the same oxygen partial pressure.

Fetal haemoglobin has a higher oxygen affinity than adult haemoglobin, so at the placenta fetal blood can load oxygen released from maternal haemoglobin.

A right shift means lower affinity at a stated oxygen partial pressure; it does not mean haemoglobin carries no oxygen. Always connect curve position to loading or unloading conditions.

Atherosclerosis narrows arteries through damage and plaque growth

Atherosclerosis begins when the arterial endothelium is damaged. An inflammatory response attracts white blood cells, cholesterol-rich deposits and smooth-muscle changes, forming an atheroma in the artery wall.

Endothelial damage → inflammation → low-density lipoprotein enters the wall → macrophages form foam cells → plaque grows and narrows the lumen. A rough plaque can also encourage clot formation.

If a coronary artery lumen narrows, resistance to blood flow rises and cardiac muscle receives less oxygen. A plaque that ruptures may trigger a thrombus that blocks flow suddenly.

The disease links risk factors to a mechanism: high blood pressure can damage the endothelium, while smoking, diabetes and high LDL increase the likelihood of plaque development.

A risk factor raises probability rather than guaranteeing disease. Atherosclerosis is plaque formation in the artery wall; thrombosis is a clotting event that may follow it.

Blood clotting converts a damaged surface into a fibrin mesh

Damage to a blood vessel releases thromboplastin. In the presence of calcium ions, it helps convert soluble prothrombin into thrombin; thrombin converts soluble fibrinogen into insoluble fibrin.

Thrombin activates more clotting reactions and fibrin fibres form a mesh across the wound. Platelets become trapped, the mesh contracts and a clot reduces blood loss while tissue repair begins.

A cut exposes tissue and activates the cascade locally. The resulting fibrin network stays near the damaged vessel rather than turning all circulating fibrinogen into a body-wide clot.

The cascade amplifies a small trigger, but inhibitors and the intact endothelium limit clotting to the injury. If a clot forms inside an artery it can obstruct blood flow and cause thrombosis.

Prothrombin and fibrinogen are soluble plasma proteins; thrombin and fibrin are the active enzyme/product in the sequence. Do not reverse these pairs.

Cardiovascular risk factors act through different mechanisms

A risk factor increases the probability of cardiovascular disease (CVD); it does not guarantee an individual outcome. Risk usually reflects several interacting factors.

Smoking damages endothelium, raises blood pressure and increases clot risk. High blood pressure increases mechanical damage to artery linings. Inactivity and an energy-rich diet can promote obesity, hypertension and an adverse blood-lipid profile. Inherited alleles can alter lipid handling or blood pressure.

Age, biological sex and inherited susceptibility are non-modifiable, whereas smoking, activity and diet are modifiable. A non-modifiable factor can identify higher baseline risk; a modifiable factor offers a route to reduce risk.

An association is not individual certainty, and one factor rarely acts alone. Explain the biological route from the factor to endothelial damage, atheroma, pressure or thrombosis rather than merely repeating that risk rises.

Antioxidants are a mechanism to test, not a guarantee of lower CVD risk

Antioxidants can react with reactive molecules and may reduce oxidative damage. This gives a plausible link between diet and cardiovascular disease, but plausibility is not the same as demonstrated protection.

Oxidative damage can affect lipids and the arterial endothelium, yet CVD is also shaped by blood pressure, LDL, smoking, diabetes and activity. A single nutrient cannot be treated as an isolated cause.

A study may find that people who eat more fruit have lower CVD risk. The result could reflect antioxidants, fibre, lower saturated-fat intake or other lifestyle differences, so the design must address confounding.

Prefer evidence from controlled interventions or well-adjusted longitudinal studies over a single correlation. Report the strength and limits of the evidence before recommending a behaviour.

“Contains antioxidants” does not prove a food prevents CVD, and a supplement trial is not automatically equivalent to a whole-diet effect. Separate mechanism, association and outcome evidence.

Measure vitamin C by decolourising DCPIP

Vitamin C reduces blue DCPIP to a colourless form. A sample with more vitamin C decolourises a fixed amount of DCPIP using a smaller sample volume, provided the endpoint and conditions are the same.

  1. Prepare or obtain a vitamin C solution of known concentration.
  2. Place a fixed volume and concentration of DCPIP in a tube.
  3. Add the standard dropwise while mixing until the blue colour just disappears; record the volume and repeat.
  4. Prepare each food or drink sample by the same extraction and dilution method.
  5. Titrate each sample to the same endpoint, repeat and calculate a mean.

For a fixed DCPIP amount, the vitamin C amount reaching the endpoint is constant. Compare the mean standard and sample volumes, including every dilution factor, to calculate vitamin C concentration; report appropriate units such as mgcm3\mathrm{mg\,cm^{-3}}.

Keep DCPIP volume/concentration, extraction mass, dilution, temperature and endpoint judgement constant. Minimise heating and air exposure because vitamin C oxidises.

The result estimates vitamin C under the chosen redox conditions; strongly coloured samples can obscure the endpoint and require a blank or instrumental method.

Risk data require a separation of description, association and causation

Describe what the data show before explaining it: identify the population, units, trend and comparison. A correlation means two variables change together; it does not by itself show that one causes the disease.

Confounders such as age, income, activity or access to healthcare can influence both the risk factor and the outcome. Relative risk, absolute risk and sample size answer different questions.

If disease prevalence rises with smoking exposure, state the size and direction of the association, then ask whether dose, timing, biological mechanism and alternative explanations support a causal interpretation.

Use confidence intervals or statistical tests where supplied, avoid extrapolating beyond the population studied, and distinguish an individual prediction from a population estimate.

A statistically significant association can still be biased; a non-significant result does not prove no effect. “Linked to” and “causes” are not interchangeable.

A health-risk study is credible only when its design matches the claim

Judge a study by asking who was sampled, how exposure and outcome were measured, whether comparison groups are appropriate, and whether the time sequence can support the claim. A large sample cannot rescue a biased design.

Check representativeness and sample size; define variables consistently; control or stratify confounders; use blinding or randomisation where possible; and report drop-outs and measurement uncertainty.

A questionnaire finding that diet and CVD are associated may suffer recall bias and self-selection. A prospective cohort with repeated measurements gives stronger temporal evidence but still cannot control every confounder.

Validity concerns whether the design supports the intended inference; reliability concerns consistency. Ethical limits may make a randomised exposure impossible, so conclusions should match the design.

An observational study can support an association without proving causation. Do not treat “peer reviewed” or “statistically significant” as substitutes for examining the method.

Perceived risk is shaped by salience, not just probability

People often judge risk using vividness, familiarity and perceived control rather than the measured probability alone. Rare dramatic events can feel more likely than common gradual hazards.

Actual risk is estimated from population data and an agreed time frame; perceived risk is an individual judgement that can be shifted by media coverage, personal experience and trust in the source.

A person may fear a rare treatment side effect after seeing a news story but underestimate the cumulative CVD risk of smoking because it is familiar. The decision changes when absolute risk and comparison groups are made explicit.

Good communication does not simply replace perception with a number: it explains denominator, time horizon, uncertainty and the action that can change risk.

A perception is not “wrong” merely because it differs from an average statistic; context and values matter. But a decision should not confuse emotional salience with measured probability.

Use HDL, LDL and intervention evidence to interpret CVD risk

Cholesterol travels in lipoproteins. LDL delivers cholesterol from the liver towards tissues; high LDL concentrations are associated with cholesterol deposition in artery walls. HDL participates in reverse cholesterol transport towards the liver.

When analysing a graph or table, identify units, groups, sample size and uncertainty. Describe how CVD incidence changes with total cholesterol, LDL or HDL, then distinguish relative from absolute risk and association from causation.

A causal case is stronger when several lines agree: risk rises with sustained LDL exposure, inherited conditions that raise LDL produce early CVD, and interventions that lower LDL also lower later cardiovascular events. A plausible mechanism links LDL entry and modification in artery walls to inflammation and atheroma.

HDL is not a guarantee of protection and LDL is not a diagnosis by itself. Overall risk also depends on blood pressure, smoking, diabetes, age and genetics.

Use scientific evidence to reduce CHD risk without overclaiming

Reducing coronary heart disease (CHD) risk combines biological knowledge with an evidence-based decision: improve diet and activity, avoid smoking, manage blood pressure and interpret body-composition measures in context.

Body mass index and waist-to-hip ratio are screening indicators, not complete diagnoses. They can help identify groups for further assessment, but muscle mass, age, sex and ethnicity affect their meaning.

A high BMI may reflect muscle rather than excess adipose tissue; a central fat pattern may still signal metabolic risk. A sensible conclusion uses the measurement with blood pressure, lipids, family history and activity data.

When comparing an intervention, check whether risk-factor changes are measured over a relevant time and whether the study controls confounding. Translate the evidence into a proportionate recommendation rather than a guarantee.

“Lowers risk” is not “prevents disease”. Population evidence supports probability changes, not certainty for one individual.

Balance the benefits and risks of CVD medicines

CVD medicines target different processes, so their benefit must be matched to the patient's risk and weighed against adverse effects.

Treatment Main benefit Important risk or limitation
Antihypertensive Lowers blood pressure and reduces vessel/heart strain Excessive pressure reduction can cause dizziness or fainting; effects depend on drug class
Statin Lowers LDL and reduces atherosclerotic-event risk Can cause muscle symptoms; liver effects require attention
Anticoagulant Reduces formation or growth of fibrin-rich clots Increases bleeding risk and may require dose monitoring
Platelet inhibitor Reduces platelet aggregation and arterial thrombosis Increases bleeding and may irritate the stomach

A person at high thrombotic risk may gain a large absolute benefit from clot prevention, while the same drug may be unsuitable when bleeding risk is high. Treatment combinations require monitoring because benefits and harms can add.

Anticoagulants and platelet inhibitors act on different parts of clot formation; neither dissolves an established atheroma. A drug that lowers one risk factor does not remove all CVD risk.